Prognostic factors in breast cancer: the predictive value of the Nottingham Prognostic Index in patients with a long-term follow-up that were treated in a single institution

By D'Eredita' G.   Giardina C.   Martellotta M.   Natale T.   Ferrarese F.  

European Journal of Cancer, Vol. 37, Iss. 5, 2001-03 ,pp. : 591-596

Elsevier

Access to resources Recommend Favorite

Biological considerations in locally advanced breast cancer treated with anthracycline-based neoadjuvant chemotherapy: thymidine labelling index is an independent indicator of clinical outcome

By Ozmen V.  

Breast Cancer Research and Treatment, Vol. 68, Iss. 2, 2001-07 ,pp. : 147-157

Springer Publishing Company

Access to resources Recommend Favorite

HER2 as a prognostic and predictive marker for breast cancer

By Cooke T.   Reeves J.   Lanigan A.   Stanton P.  

Annals of Oncology, Vol. 12, Iss. 12, 2001-12 ,pp. : 23-28

Springer Publishing Company

Access to resources Recommend Favorite

Predictive Biomarkers in Breast Cancer: Their Value in Neoadjuvant Chemotherapy

By Fuksa L.   Micuda S.   Grim J.   Ryska A.   Hornychova H.  

Cancer Investigation, Vol. 30, Iss. 9, 2012-10 ,pp. : 663-678

Informa Healthcare

Access to resources Recommend Favorite

The prognostic value of apoptotic and proliferative markers in breast cancer

By Engels Charla   Ruberta Francesca   Kruijf Esther   Pelt Gabi   Smit Vincent   Liefers Gerrit   Matsushima Tomoko   Shibayama Masaki   Ishihara Hideki   Velde Cornelis   Kuppen Peter  

Breast Cancer Research and Treatment, Vol. 142, Iss. 2, 2013-11 ,pp. : 323-339

Springer Publishing Company

Access to resources Recommend Favorite